MissionIR Articles
Category: Small Cap News
-
VistaGen Therapeutics Secures Development Support for New Drug Candidate forHuntington’s Disease
VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics using embryonic stem cell technologies, announced today that the High Q Foundation, Inc. has agreed…
Search Articles
Latest Articles
- MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
- MissionIRNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Targets Untapped Potential of Jameson Land Basin
- MissionIRNewsBreaks – Perpetuals.com Ltd (NASDAQ: PDC) CEO to Present at Emerging Growth Conference
- MissionIRNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Completes MagicBlocks Acquisition
- MissionIRNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Expands Campus Safety Presence With UMBC Deployment